Long-term outcomes of patients treated with an EPOCHL regimen as first-line chemotherapy for newly diagnosed extranodal natural killer/T-cell lymphoma: a retrospective single-center study-Reference-Cited by-同舟云学术

Long-term outcomes of patients treated with an EPOCHL regimen as first-line chemotherapy for newly diagnosed extranodal natural killer/T-cell lymphoma: a retrospective single-center study

Published:2019-09-13 Issue:2 Volume:61 Page:337-343
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Wei Liqiang¹,Wang Jingwen¹^ORCID,Ye Jin¹,Yang Lei¹,Cong Jia¹,Li Xin¹,Wu Yiping¹,Cui Xueying¹,Ding Jing¹,Yao Na¹,Yang Jing¹

Affiliation:

1. Department of Haematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1663421

Reference30 articles.

1. 2016 US lymphoid malignancy statistics by World Health Organization subtypes

2. Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution

3. Distribution of Lymphoid Neoplasms in China

4. International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

5. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of extranodal NK/T-cell lymphoma: From past to future;Frontiers in Immunology;2023-02-07

2. Comparison of chemotherapy with or without asparaginase for extranodal nasal NK/T‐cell lymphoma in children and adolescents;Pediatric Blood & Cancer;2021-01-23

3. LncRNA BCYRN1-induced autophagy enhances asparaginase resistance in extranodal NK/T-cell lymphoma;Theranostics;2021

4. A proposal for a prognostic index for non-nasal type natural killer/T cell lymphoma after asparaginase-based treatment;Annals of Hematology;2020-09-25

5. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG;Blood Advances;2020-07-13